26.04 USD
0.94
3.48%
Last update Dec 18, 1:21 PM EST
Main market
Day range
25.965
27.535
Previous close
26.98000
Open
27.01
Access this stock data via API
Subscribe
Immunovant Inc.
26.04
0.94
3.48%

Financials

Income statement

Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 0 0 0 0
Cost of revenue
Gross profit
Operating expense
Research & development 114.2M 101.2M 93.7M 94.5M
Selling general and admin 17.5M 26.0M 20.2M 19.8M
Other operating expenses
Operating income -131.8M -127.2M -113.8M -114.3M
Non operating interest income
Income 5.6M 6.3M 6.9M 4.6M
Expense
Other income expense 250K 1.2M 1.1M -1.3M
Pretax income -125.9M -119.7M -105.9M -111.0M
Tax provision 594K 913K 583K 152K
Net income -126.5M -120.6M -106.4M -111.1M
Basic EPS -0.7 -0.7 -0.6 -0.8
Diluted EPS -0.7 -0.7 -0.6 -0.8
Basic average shares 173.6M 170.9M 166.7M 146.9M
Diluted average shares 173.6M 170.9M 166.7M 146.9M
EBITDA -131.7M -127.1M -113.7M -114.2M
Net income from continuing op. -126.5M -120.6M -106.4M -111.1M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 2 hours 36 minutes

13:23
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).